These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33377877)

  • 1. The Association between Peripheral Th17, Th1, IL-17, and IFN-γ Levels and TACE Response in Patients with Unresectable Hepatocellular Carcinoma with or without Cirrhosis.
    Hasan I; Gani RA; Lesmana LA; Kresno SB; Pandelaki J; Suwarto S
    Acta Med Indones; 2020 Oct; 52(4):326-333. PubMed ID: 33377877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study.
    Liao Y; Wang B; Huang ZL; Shi M; Yu XJ; Zheng L; Li S; Li L
    PLoS One; 2013; 8(4):e60444. PubMed ID: 23565248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.
    Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y
    BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Wu Y; Fan W; Xue M; Zhong B; Zhang S; Wang Y; Yao W; Zhao Y; Li J
    Oncologist; 2019 Dec; 24(12):e1489-e1495. PubMed ID: 31249138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study.
    Orlacchio A; Chegai F; Roma S; Merolla S; Bosa A; Francioso S
    Radiol Med; 2020 Jan; 125(1):98-106. PubMed ID: 31583558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 and Th1 Lymphocytes Are Correlated with Chronic Periodontitis.
    Chen XT; Chen LL; Tan JY; Shi DH; Ke T; Lei LH
    Immunol Invest; 2016; 45(3):243-54. PubMed ID: 27019379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Peripheral Blood Treg Cell Proportion in Hepatocellular Carcinoma Patients After Transarterial Chemoembolization With Microparticles.
    Ren Z; Yue Y; Zhang Y; Dong J; Liu Y; Yang X; Lin X; Zhao X; Wei Z; Zheng Y; Wang T
    Front Immunol; 2021; 12():624789. PubMed ID: 33717135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy.
    Zhou D; Gu FM; Gao Q; Li QL; Zhou J; Miao CH
    World J Gastroenterol; 2012 Jun; 18(24):3089-98. PubMed ID: 22791944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
    Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
    Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinoma.
    Yan J; Liu XL; Xiao G; Li NL; Deng YN; Han LZ; Yin LC; Ling LJ; Liu LX
    PLoS One; 2014; 9(5):e96080. PubMed ID: 24867183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of transcatheter arterial chemoembolization on cellular immune function and regulatory T cells in patients with hepatocellular carcinoma.
    Liao J; Xiao J; Zhou Y; Liu Z; Wang C
    Mol Med Rep; 2015 Oct; 12(4):6065-71. PubMed ID: 26239573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma.
    Jekarl DW; Lee S; Kwon JH; Nam SW; Kim M; Kim Y; Jang JW
    PLoS One; 2019; 14(11):e0224318. PubMed ID: 31751357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage.
    Boniface K; Blumenschein WM; Brovont-Porth K; McGeachy MJ; Basham B; Desai B; Pierce R; McClanahan TK; Sadekova S; de Waal Malefyt R
    J Immunol; 2010 Jul; 185(1):679-87. PubMed ID: 20511558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization.
    Lee HL; Jang JW; Lee SW; Yoo SH; Kwon JH; Nam SW; Bae SH; Choi JY; Han NI; Yoon SK
    Sci Rep; 2019 Mar; 9(1):3260. PubMed ID: 30824840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
    Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
    Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts.
    Kato H; Endres J; Fox DA
    Mod Rheumatol; 2013 Nov; 23(6):1140-50. PubMed ID: 23306426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4
    de Franca MNF; Rodrigues LS; Barreto AS; da Cruz GS; Aragão-Santos JC; da Silva AM; de Jesus AR; Palatnik-de-Sousa CB; de Almeida RP; Corrêa CB
    Front Immunol; 2024; 15():1277557. PubMed ID: 38410517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization.
    Wu YQ; Fan WZ; Xue M; Guo J; Wei JL; Wang Y; Yao W; Zhao Y; Li JP
    Clin Transl Oncol; 2020 Jan; 22(1):70-80. PubMed ID: 31183764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
    Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1167-74. PubMed ID: 25675849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.